Angela Celetti
Overview
Explore the profile of Angela Celetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caggiano R, Prokhorova E, Duma L, Schutzenhofer K, Lauro R, Catara G, et al.
Neoplasia
. 2024 Nov;
59:101092.
PMID: 39615107
The ADP-ribosyl hydrolases PARG and ARH3 counteract PARP enzymatic activity by removing ADP-ribosylation. PARG and ARH3 activities have a synthetic lethal effect; however, the specific molecular mechanisms underlying this response...
2.
Criscuolo D, Morra F, Celetti A
Explor Target Antitumor Ther
. 2022 Nov;
3(5):570-581.
PMID: 36338517
Solute carrier family 7 member 11 (SLC7A11; also known as xCT), a key component of the cystine/glutamate antiporter, is essential for the maintenance of cellular redox status and the regulation...
3.
Morra F, Merolla F, Damia G, Ricci F, Varricchio S, Ilardi G, et al.
J Exp Clin Cancer Res
. 2022 Aug;
41(1):245.
PMID: 35964058
Background: Treatment with PARP inhibitors (PARPi) is primarily effective against high-grade serous ovarian cancers (HGSOC) with BRCA1/2 mutations or other deficiencies in homologous recombination (HR) repair mechanisms. However, resistance to...
4.
Miro C, Di Giovanni A, Murolo M, Cicatiello A, Nappi A, Sagliocchi S, et al.
Cancer Lett
. 2022 Feb;
532:215581.
PMID: 35134514
Prostate Cancer (PCa) is the most commonly diagnosed non-cutaneous cancer in males and the fifth leading cause of death worldwide. The majority of PCas are androgen-sensitive, with a significant up-regulation...
5.
Morra F, Merolla F, Marino F, Catalano R, Franco R, Chieffi P, et al.
Heliyon
. 2021 Nov;
7(11):e08399.
PMID: 34841108
Coiled-coil domain containing 6 (CCDC6) is a tumour suppressor gene involved in apoptosis and DNA damage response. CCDC6 is known to be functionally impaired upon gene fusions, somatic mutations, and...
6.
Napolitano V, Russo D, Morra F, Merolla F, Varricchio S, Ilardi G, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359721
Head and neck squamous cell carcinoma (HNSCC) includes a group of aggressive malignancies characterized by the overexpression of the epidermal growth factor receptor (EGFR) in 90% of cases. Neuropilin-1 (NRP-1)...
7.
Merolla F, Ilardi G, Di Spigna G, Russo D, Martino F, Varricchio S, et al.
Oral Oncol
. 2021 Jul;
120:105367.
PMID: 34237585
To date, a very small number of serum biomarkers have been identified for clinical use in squamous carcinomas of the head and neck region. Chromatin Assembly Factor-1 (CAF-1) heterotrimeric complex...
8.
Staibano S, Ilardi G, Leone V, Luise C, Merolla F, Esposito F, et al.
BMC Cancer
. 2021 Jan;
21(1):100.
PMID: 33504337
No abstract available.
9.
Poltronieri P, Celetti A, Palazzo L
Cells
. 2021 Jan;
10(1).
PMID: 33440786
Mono(ADP-ribose) transferases and mono(ADP-ribosyl)ating sirtuins use NAD to perform the mono(ADP-ribosyl)ation, a simple form of post-translational modification of proteins and, in some cases, of nucleic acids. The availability of NAD...
10.
Russo D, Merolla F, Varricchio S, Salzano G, Zarrilli G, Mascolo M, et al.
Biomed Rep
. 2020 Apr;
12(5):290.
PMID: 32257193
[This corrects the article DOI: 10.3892/br.2018.1136.].